Affimers are revolutionary new affinity proteins that have been engineered to address many of the negative performance issues experienced with antibodies such as poor specificity, batch-to-batch variation and the long time taken to generate new antibodies.
The Avacta Life Sciences catalogue contains binders to targets in research areas covering Acute Phase Proteins, Anti-Immunoglobulin, Cell Cycle, Cell Signalling, Immunology, Metabolism and Tags - with more being launched soon.
We also offer a custom Affimer service. A typical project can be delivered in just 7 weeks!
Critically, switching from antibodies to Affimers requires no change in working procedures - making it a simple like‑for‑like swap.
Affimers are revolutionising the way life scientists work. Read what our customers are saying:
“ Our research interests lie in studying the function of FcgR’s in autoimmune and inflammatory diseases. The Affimers we’ve isolated have shown remarkable specificity and have proven useful not only as detection tools, but also for blocking receptor function. Furthermore, crystallisation of the Affimer with the receptors have identified allosteric inhibitors. Overall we’re delighted with the results and hope to develop them into therapeutics.”
Professor Ann W Morgan
Hon. Consultant Rheumatologist
University of Leeds
Testimonials
Read what Life Scientists are saying
about Affimers.
Find out more
View our FcgR data poster to learn
more about Affimers.
